DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Geisinger Clinic
Massachusetts General Hospital
Thomas Jefferson University
H. Lee Moffitt Cancer Center and Research Institute
Vanderbilt-Ingram Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
University of Iowa
University of Utah
Ohio State University Comprehensive Cancer Center
FindCure Biosciences (ZhongShan) Co., Ltd.
Cedars-Sinai Medical Center
Guizhou Provincial People's Hospital
University of California, Davis
Abramson Cancer Center at Penn Medicine
University of Alabama at Birmingham
Radiopharm Theranostics, Ltd
University of Pennsylvania
Baylor Research Institute
Stanford University
Rutgers, The State University of New Jersey
Poitiers University Hospital
University of Texas Southwestern Medical Center
University of Colorado, Denver
University of Alabama at Birmingham
University of Oklahoma
Assiut University
Stony Brook University
Shandong Cancer Hospital and Institute
Var2 Pharmaceuticals
Mayo Clinic
University of Wisconsin, Madison
Mayo Clinic
Shanghai Juncell Therapeutics
Milton S. Hershey Medical Center
Baylor Research Institute
University of Kansas Medical Center
Novartis
UNC Lineberger Comprehensive Cancer Center
SOLTI Breast Cancer Research Group
Jonsson Comprehensive Cancer Center
Pure Biologics S.A.
Pure Biologics S.A.
University of Wisconsin, Madison
The University of Texas Health Science Center at San Antonio
Peking Union Medical College Hospital
Affiliated Hospital of Jiangnan University
Affiliated Hospital of Jiangnan University
Case Comprehensive Cancer Center
Emory University